research triangle park

RESEARCH TRIANGLE PARK, N.C. -- Following kidney transplantation, a planned phase out of a calcineurin inhibitor from sirolimus (Rapamune)-based immunosuppression improves outcomes and reduces costs, a statistical model of the strategy suggested.

Last summer, we posted about allegations that Dr David Schwartz, then-director of the US National Institute of Environmental Health Sciences (part of the National Institutes, of Health, NIH), had several significant and previously undisclosed conflicts of interest.